Buy Generic Dexlansoprazole Online
|
|
Generic Dexlansoprazole 30mg
Package | Price | Per Pill | Shipping | Order | |
30mg x 30 pills | £44.01 | £1.47 | Add to Cart | ||
30mg x 60 pills | £75.16 | £1.25 | Add to Cart | ||
30mg x 90 pills | £100.21 | £1.11 | Add to Cart | ||
30mg x 120 pills | £112.99 | £0.94 | Add to Cart | ||
30mg x 180 pills | £138.53 | £0.77 | Add to Cart |
Generic Dexlansoprazole 60mg
Package | Price | Per Pill | Shipping | Order | |
60mg x 30 pills | £59.29 | £1.98 | Add to Cart | ||
60mg x 60 pills | £93.83 | £1.56 | Add to Cart | ||
60mg x 90 pills | £125.27 | £1.39 | Add to Cart | ||
60mg x 120 pills | £150.33 | £1.25 | Free Airmail shipping |
Add to Cart | |
60mg x 180 pills | £206.33 | £1.14 | Free Airmail shipping |
Add to Cart |
Generic Dexlansoprazole Information
Introduction
Dexlansoprazole is a proton‑pump inhibitor (PPI) used to reduce gastric acid secretion. It belongs to the Gastro Health medication group and is prescribed for several acid‑related disorders in the United Kingdom. The active compound, dexlansoprazole, provides long‑lasting acid suppression, which helps heal the oesophageal lining and alleviates symptoms such as heartburn and regurgitation. In addition to its primary indication for gastro‑oesophageal reflux disease (GERD), dexlansoprazole is employed in the maintenance of healed erosive oesophagitis and for the treatment of ulcer‑type dyspepsia.
What is Dexlansoprazole?
Dexlansoprazole is the generic version of the brand‑name drug Dexilant, containing the same active compound, dexlansoprazole. It was developed by Takeda Pharmaceutical Company and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK. As a generic, it offers the same therapeutic effect as the branded product at a lower cost. Our online pharmacy provides this generic alternative as a cost‑effective treatment option for patients who require long‑term acid suppression.
How Dexlansoprazole Works
Dexlansoprazole belongs to the class of proton‑pump inhibitors. It is a pro‑drug that becomes activated in the acidic environment of the secretory canaliculi of gastric parietal cells. Once activated, it binds covalently to the H⁺/K⁺‑ATPase pump (the “proton pump”), irreversibly inhibiting the final step of gastric acid production. This inhibition reduces both basal and stimulus‑induced acid secretion. Dexlansoprazole is formulated with a dual‑delayed‑release (DDR) technology, delivering two separate releases of the drug: an initial dose that begins to act within 1–2 hours, and a second release occurring 4–5 hours later. This results in prolonged acid control over a 24‑hour period, allowing flexible dosing times and improved symptom control compared with single‑release PPIs.
Conditions Treated with Dexlansoprazole
- Gastro‑oesophageal reflux disease (GERD) – chronic reflux of gastric contents into the oesophagus causing heartburn, regurgitation, and oesophagitis. In the UK, up to 25 % of adults experience weekly heartburn, making effective acid suppression essential.
- Erosive oesophagitis – inflammation and ulceration of the oesophageal lining caused by acid exposure. Dexlansoprazole promotes healing and maintains remission.
- Helicobacter pylori eradication (as part of combination therapy) – used together with antibiotics and other agents to improve eradication rates by reducing gastric acidity.
- Symptomatic non‑erosive reflux disease (NERD) – patients with reflux symptoms but without visible oesophageal erosion benefit from the prolonged acid control.
- Peptic ulcer disease (adjunct) – when used in combination regimens, dexlansoprazole can support ulcer healing by maintaining a higher gastric pH.
Who is Dexlansoprazole For?
Dexlansoprazole is suitable for adult patients who require durable suppression of gastric acid, particularly when:
- Symptoms of GERD persist despite lifestyle modifications.
- Endoscopic evaluation has confirmed erosive oesophagitis (Los Angeles grades A‑D).
- Long‑term maintenance therapy is needed after healing of oesophageal lesions.
- A flexible dosing schedule is desired (e.g., patients who have difficulty taking medication at a fixed time each day).
Contra‑indications include known hypersensitivity to dexlansoprazole or other PPIs, and concomitant use of rilpivirine‑containing antiretroviral therapy. Caution is advised in patients with severe liver impairment, as metabolism is primarily hepatic. Elderly patients may require dose adjustment if renal function is compromised.
Risks, Side Effects, and Interactions
Common
- Headache
- Diarrhoea or constipation
- Nausea
- Abdominal pain or flatulence
- Dry mouth
These events are usually mild, transient, and resolve without medical intervention.
Rare
- Vitamin B12 deficiency (particularly with prolonged use)
- Hypomagnesemia
- Metabolic bone disease (osteopenia/osteoporosis)
- Clostridioides difficile infection (associated with altered gut flora)
Monitoring of serum magnesium and bone health is recommended for patients on continuous therapy beyond one year.
Serious
- Severe allergic reactions (angioedema, anaphylaxis)
- Acute interstitial nephritis
- Stevens‑Johnson syndrome / toxic epidermal necrolysis
- Liver enzyme elevation (hepatitis)
Any sign of a serious reaction warrants immediate medical attention and discontinuation of the medication.
Drug–Drug Interactions
- Clopidogrel – co‑administration may reduce the antiplatelet effect of clopidogrel; consider alternative antiplatelet agents.
- Atazanavir, Nelfinavir – PPIs can lower plasma levels of these antiretrovirals; dosage adjustment or timing separation is required.
- Warfarin – PPIs may increase INR; monitor coagulation parameters.
- Methotrexate (high dose) – reduced renal clearance may occur; monitor serum levels.
- Ketoconazole, Itraconazole – decreased absorption due to higher gastric pH; alternative antifungal regimens may be needed.
Patients should provide a complete medication list to their prescriber to avoid clinically significant interactions.
Practical Use: Dosing, Missed Dose, Overdose
- Standard dosing for GERD – 30 mg taken orally once daily. The dual‑release tablet may be taken with or without food, at any time of day.
- Healing erosive oesophagitis – 60 mg once daily for up to 8 weeks, followed by a maintenance dose of 30 mg daily.
- Paediatric use – not approved; dexlansoprazole is indicated for adults only.
- Renal or hepatic impairment – no dosage adjustment is required for mild to moderate impairment; severe hepatic disease may need physician oversight.
Missed dose: If a dose is missed, take it as soon as remembered unless it is within 12 hours of the next scheduled dose. In that case, skip the missed dose and resume the regular schedule; do not double‑dose.
Overdose: Symptoms may include dizziness, abdominal discomfort, or nausea. Dexlansoprazole has a wide safety margin; however, seek urgent medical advice if large quantities are ingested.
Precautions: Avoid concurrent use of high‑dose alcohol or NSAIDs without gastro‑protective measures, as the risk of gastrointestinal bleeding may increase. Patients with known hypomagnesemia should have serum magnesium checked prior to initiation and periodically thereafter.
Buying Dexlansoprazole from Our Online Pharmacy
Dexlansoprazole can be purchased from our online pharmacy in the UK, offering a discreet and reliable service for patients who need affordable access to this medication. Key benefits include:
- Affordable pricing – our generic product is priced close to the manufacturer’s cost, providing a cost‑effective alternative to branded options.
- Verified quality – we partner only with licensed overseas suppliers that comply with Good Manufacturing Practice (GMP) standards, ensuring each tablet meets strict potency and purity criteria.
- Guaranteed delivery – discreet packaging is shipped via express service (delivery within 7 days) or standard airmail (approximately 3 weeks), with tracking available for all orders.
- Online‑only accessibility – the pharmacy broker model enables patients without local pharmacy stock or insurance coverage to obtain the medication safely and anonymously.
- Privacy‑focused service – all personal data is encrypted, and shipments are labelled generically to protect confidentiality.
Our online pharmacy thus provides a safe, convenient, and economical route for patients seeking sustained acid suppression therapy.
FAQ
-
Can dexlansoprazole be taken with meals?
Yes, dexlansoprazole may be taken with or without food. The dual‑release formulation is designed to work regardless of meals, allowing flexibility for patients with irregular eating patterns. -
What is the appearance of a dexlansoprazole tablet?
The generic tablet is usually a white, film‑coated, oval‑shaped tablet bearing the imprint “30 mg” or “60 mg” depending on strength. In the UK, the imprint is standardized across licensed manufacturers. -
Is a prescription required to import dexlansoprazole for personal use in the UK?
Personal importation of medicines for non‑commercial use is permitted under UK law if the product is for a genuine personal need, the supply is limited to a three‑month supply, and the medication is not a controlled substance. However, it is advisable to retain evidence of a valid prescription for customs clearance. -
How should dexlansoprazole be stored in a hot climate?
Store the tablets at a controlled room temperature, ideally between 15 °C and 30 °C, away from direct sunlight and moisture. In hot climates, keep the medication in a cool, dry place, such as a cupboard away from ovens or radiators, to prevent degradation. -
What inactive ingredients are present in the generic formulation?
In the UK‑licensed generic, common excipients include microcrystalline cellulose, magnesium stearate, and hypromellose as the film coating. No lactose or gluten is typically added, but patients with specific sensitivities should verify the ingredient list on the packaging. -
Can dexlansoprazole affect results of drug testing?
Dexlansoprazole is not known to cause false‑positive results in standard occupational drug screens (e.g., for cannabinoids, opiates, or amphetamines). Routine therapeutic drug monitoring for PPIs is not required. -
Are there any known differences between the US and EU formulations of dexlansoprazole?
The active ingredient and dual‑release technology are the same, but some regional formulations may vary in tablet colour, imprint, or specific inactive filler composition, reflecting local regulatory requirements. -
What were the pivotal clinical trials that established dexlansoprazole’s efficacy?
Phase III trials (e.g., the “DEXLANSO‑GERD” study) compared dexlansoprazole 30 mg once daily to esomeprazole 40 mg, demonstrating non‑inferior healing rates of erosive oesophagitis at 8 weeks, with a quicker onset of symptom relief due to the dual‑release mechanism. -
How does dexlansoprazole compare with older PPIs such as omeprazole?
Dexlansoprazole provides a broader therapeutic window, allowing once‑daily dosing at any time of day, while omeprazole requires administration before breakfast for optimal effect. Clinical data suggest comparable healing rates but a lower incidence of nocturnal heartburn with dexlansoprazole. -
Is it safe to travel with dexlansoprazole in hand luggage?
Yes, the medication can be carried in hand luggage. Keep the tablets in the original packaging with a copy of the prescription or a doctor’s note if requested by security personnel. Ensure the container is sealed to prevent spillage. -
What should I do if I develop a rash while taking dexlansoprazole?
A mild rash may be a benign skin reaction, but any new rash, especially if accompanied by swelling, difficulty breathing, or fever, should prompt immediate discontinuation of the drug and urgent medical evaluation, as it could signify a serious hypersensitivity reaction.
Glossary
- Proton‑pump inhibitor (PPI)
- A class of medications that irreversibly block the hydrogen‑potassium ATPase enzyme in gastric parietal cells, reducing stomach acid production.
- Dual‑delayed‑release (DDR) technology
- A formulation design that releases the drug in two separate phases, extending the duration of action and allowing more flexible dosing.
- Erosive oesophagitis
- Inflammation and ulceration of the oesophageal lining caused by prolonged exposure to gastric acid, graded by endoscopic appearance (Los Angeles classification).
- Hypomagnesemia
- A condition characterised by low serum magnesium levels, which can occur with long‑term PPI use and may lead to muscle cramps, arrhythmias, or seizures.
⚠️ Disclaimer
The information provided about Dexlansoprazole is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Dexlansoprazole for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.